feed,title,long_url,short_url
Benzinga,Opdivo's Subcutaneous Formulation Shows Promise in Advanced Kidney Cancer: Bristol Myers Squibb's Latest Findings,https://benzinga.com/general/biotech/23/10/35328430/opdivos-subcutaneous-formulation-shows-promise-in-advanced-kidney-cancer-bristol-myers-squibbs-la,https://da.gd/P1Ymr
